MENU
+Compare
RANI
Stock ticker: NASDAQ
AS OF
Sep 26, 04:59 PM (EDT)
Price
$0.48
Change
-$0.00 (-0.00%)
Capitalization
22.95M

RANI Rani Therapeutics Holdings Forecast, Technical & Fundamental Analysis

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections... Show more

RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RANI with price predictions
Sep 25, 2025

RANI's Stochastic Oscillator dives oversold zone

The Stochastic Oscillator for RANI moved into oversold territory on September 25, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RANI just turned positive on September 19, 2025. Looking at past instances where RANI's MACD turned positive, the stock continued to rise in of 37 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RANI advanced for three days, in of 227 cases, the price rose further within the following month. The odds of a continued upward trend are .

RANI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 63 cases where RANI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RANI as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

RANI moved below its 50-day moving average on August 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for RANI crossed bearishly below the 50-day moving average on September 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RANI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.381) is normal, around the industry mean (19.714). P/E Ratio (0.000) is within average values for comparable stocks, (54.201). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.145). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (13.141) is also within normal values, averaging (346.197).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RANI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RANI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RANI is expected to report earnings to fall 7.39% to -16 cents per share on November 12

Rani Therapeutics Holdings RANI Stock Earnings Reports
Q3'25
Est.
$-0.17
Q2'25
Beat
by $0.11
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.01
Q3'24
Beat
by $0.05
The last earnings report on August 07 showed earnings per share of -18 cents, beating the estimate of -28 cents. With 128.68K shares outstanding, the current market capitalization sits at 22.95M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2051 Ringwood Avenue
Phone
+1 408 457-3700
Employees
140
Web
https://www.ranitherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OXY46.990.10
+0.21%
Occidental Petroleum Corp
BLFY9.41-0.04
-0.42%
Blue Foundry Bancorp
BANF130.40-0.61
-0.47%
BancFirst Corp
HLF8.75-0.23
-2.56%
Herbalife Ltd
TC13.19-0.51
-3.72%
Token Cat Limited

RANI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RANI has been loosely correlated with XENE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RANI jumps, then XENE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RANI
1D Price
Change %
RANI100%
-2.20%
XENE - RANI
36%
Loosely correlated
-0.19%
ADVM - RANI
34%
Loosely correlated
-0.69%
VYGR - RANI
32%
Poorly correlated
-3.76%
VNDA - RANI
32%
Poorly correlated
-1.43%
DRUG - RANI
31%
Poorly correlated
+2.69%
More